| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1893e58a79a78de604ff4b09e05c578b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2021-05-14^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b07677060f80cee891884b7add402126
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c926ae23053c70d9de96d05ae413874
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74bca1112b3e60aa67ac0516eaedfc5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6986a9e7898e18ebd3f44151c7761a63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a944882b4d839492aa1abb8ab2d14fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c25065800fd097c2206756f438b4eb2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f452dc4ed04485f9899e3767a74caa9 |
| publicationDate |
2021-11-18^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021229238-A1 |
| titleOfInvention |
Anti-infective bicyclic peptide ligands |
| abstract |
The present invention relates to polypeptides which are covalently bound to molecular scaffolds such that two or more peptide loops are subtended between attachment points to the scaffold. In particular, the invention describes peptides which are high affinity binders of ACE2. The invention also includes pharmaceutical compositions comprising said polypeptides and to the use of said polypeptides in suppressing or treating a disease or disorder mediated by ACE2, such as infection of COVID-19 or for providing prophylaxis to a subject at risk of infection of COVID-19. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023084234-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022148971-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022148970-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022148972-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022148969-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022148968-A1 |
| priorityDate |
2020-05-15^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |